These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Investigation of the kinetics and mechanism of low endotoxin recovery in a matrix for biopharmaceutical drug products. Reich J; Tamura H; Nagaoka I; Motschmann H Biologicals; 2018 May; 53():1-9. PubMed ID: 29685804 [TBL] [Abstract][Full Text] [Related]
4. The impact of endotoxin masking on the removal of endotoxin during manufacturing of a biopharmaceutical drug product. Wespel M; Geiss M; Nägele M; Combé S; Reich J; Studts J; Stolzenberger J J Chromatogr A; 2022 May; 1671():462995. PubMed ID: 35381558 [TBL] [Abstract][Full Text] [Related]
5. Endotoxin recovery using limulus amebocyte lysate (LAL) assay. Bolden JS; Warburton RE; Phelan R; Murphy M; Smith KR; De Felippis MR; Chen D Biologicals; 2016 Sep; 44(5):434-40. PubMed ID: 27470947 [TBL] [Abstract][Full Text] [Related]
6. Masking of endotoxin in surfactant samples: Effects on Limulus-based detection systems. Reich J; Lang P; Grallert H; Motschmann H Biologicals; 2016 Sep; 44(5):417-22. PubMed ID: 27464990 [TBL] [Abstract][Full Text] [Related]
7. Biophysical Analysis of Lipopolysaccharide Formulations for an Understanding of the Low Endotoxin Recovery (LER) Phenomenon. Correa W; Brandenburg K; Zähringer U; Ravuri K; Khan T; von Wintzingerode F Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258200 [TBL] [Abstract][Full Text] [Related]
8. Supramolecular assembly of micellar aggregates is the basis of low endotoxin recovery (LER) in a drug formulation that can be resolved by a whole blood assay. Schromm AB; Correa W; Gisch N; Steiniger F; Richter W; Martinez-de-Tejada G; Brandenburg K; von Wintzingerode F Biomed Pharmacother; 2024 Apr; 173():116286. PubMed ID: 38401515 [TBL] [Abstract][Full Text] [Related]
9. The effect of refrigeration and mixing on detection of endotoxin in parenteral drugs using the Limulus Amebocyte Lysate (LAL) test. Guilfoyle DE; Yager JF; Carito SL J Parenter Sci Technol; 1989; 43(4):183-7. PubMed ID: 2769526 [TBL] [Abstract][Full Text] [Related]
10. It is time to reconsider the use of naturally-occurring endotoxins in endotoxin recovery studies: Part 2 of a BioPhorum harmonized endotoxin recovery study. Bolden J; Knight M; Montz J; One J; Stockman S; Jones SP Biologicals; 2024 Aug; 87():101779. PubMed ID: 38908364 [TBL] [Abstract][Full Text] [Related]
11. Evidence against a bacterial endotoxin masking effect in biologic drug products by limulus amebocyte lysate detection. Bolden JS; Claerbout ME; Miner MK; Murphy MA; Smith KR; Warburton RE PDA J Pharm Sci Technol; 2014; 68(5):472-7. PubMed ID: 25336418 [TBL] [Abstract][Full Text] [Related]
12. Comparison of pyrogen assays by testing products exhibiting low endotoxin recovery. Thurman TL; Lahti CJ; Mateffy JM; Forng RY; von Wintzingerode F; Silva LM; Deutschmann SM; Mozier N ALTEX; 2023; 40(1):117-124. PubMed ID: 35796330 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the rabbit pyrogen test and Limulus amoebocyte lysate (LAL) assay for endotoxin in hepatitis B vaccines and the effect of aluminum hydroxide. Park CY; Jung SH; Bak JP; Lee SS; Rhee DK Biologicals; 2005 Sep; 33(3):145-51. PubMed ID: 16055344 [TBL] [Abstract][Full Text] [Related]
15. A Validation Study of the Limulus Amebocyte Lysate Test as an End-Product Endotoxin Test for Polyvalent Horse Snake Antivenom. Sheraba NS; Diab MR; Yassin AS; Amin MA; Zedan HH PDA J Pharm Sci Technol; 2019; 73(6):562-571. PubMed ID: 30770487 [TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide Structure and the Phenomenon of Low Endotoxin Recovery. Gorman A; Golovanov AP Eur J Pharm Biopharm; 2022 Nov; 180():289-307. PubMed ID: 36272656 [TBL] [Abstract][Full Text] [Related]
17. Assay of endotoxin in human plasma using immobilized histidine, Limulus amoebocyte lysate and chromogenic substrate. Minobe S; Nawata M; Shigemori N; Watanabe T Eur J Clin Chem Clin Biochem; 1994 Oct; 32(10):797-803. PubMed ID: 7865618 [TBL] [Abstract][Full Text] [Related]
18. Optimising the use of commercial LAL assays for the analysis of endotoxin contamination in metal colloids and metal oxide nanoparticles. Li Y; Italiani P; Casals E; Tran N; Puntes VF; Boraschi D Nanotoxicology; 2015 May; 9(4):462-73. PubMed ID: 25119419 [TBL] [Abstract][Full Text] [Related]
19. Comparison of LAL and rFC Assays-Participation in a Proficiency Test Program between 2014 and 2019. Piehler M; Roeder R; Blessing S; Reich J Microorganisms; 2020 Mar; 8(3):. PubMed ID: 32188126 [TBL] [Abstract][Full Text] [Related]
20. Assessing endotoxins in equine-derived snake antivenoms: Comparison of the USP pyrogen test and the Limulus Amoebocyte Lysate assay (LAL). Solano G; Gómez A; León G Toxicon; 2015 Oct; 105():13-8. PubMed ID: 26325294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]